pH Partners

We’re thrilled to welcome Madeline Brooks to pH Partners as our Vice President of Marketing, Strategy, & Operations! Madeline brings extensive experience in brand positioning, digital marketing, and corporate strategy, with a strong track record of driving growth and operational efficiency. Before joining pH Partners, Madeline led high-impact marketing and strategy initiatives, helping organizations scale, enhance market presence, and implement data-driven decision-making. She specializes in marketing strategy, streamlining operations, and driving sustainable growth, making her a valuable addition to our leadership team. With Madeline’s strategic vision and operational expertise, we’re excited for her to help drive the next phase of growth and success at pH Partners. For more insights into Madeline’s background, please visit our website at https://lnkd.in/gJGhEvrB

Another awesome event in the books! Thanks to our co-hosts, Holland & Knight LLP and Clearwater, for helping us create a fantastic happy hour. It was the perfect opportunity to connect, unwind, and celebrate SXSW in great company! #Networking #SXSW #pHPartners

A huge THANK YOU to everyone who joined us for "Beauty Backed by Science: Pioneering the Next Era of Innovation" — your energy and enthusiasm really brought this event to life. We're so grateful to be a part of this meaningful conversation and inspiring experience. A special shoutout to our presenter and panelist, Shuman Mitra?and the rest of our incredible panelists, Daniel Chai, Sara Al-Hardan, and Michael Einziger?for sharing their expertise and perspectives. And a huge thank you to Frost for hosting us in your beautiful space! We look forward to continuing to create the next era of innovation in the health and beauty industries together!

We’re excited to have Gareth Petsch?representing?pH Partners at the HPE Miami Healthcare Conference. If you’ll be there, send him a message to schedule a time to chat. See you in Miami! #InvestmentBanking #HPE2025 #HealthcareServices #pHPartners

This past December, we had the honor of attending the Women Corporate Directors Panel Discussion, where two of our own took center stage. Gail Page, Managing Partner at pH Blueprint, served as an exceptional moderator, steering a vital conversation on the evolving role of boards in today’s financial environment. Meanwhile, Benjamin Perkins, Managing Partner at pH Partners, shared his expertise and insights alongside a distinguished panel of top healthcare investors including Frank X. Dalton, Brian R., and Randy Scott. As part of WCD’s 2024-2025 fall dinner series, this event brought together over 40 women leaders committed to fulfilling their duties as effective board members. Thank you to the panelists and attendees for making this a thought-provoking and engaging discussion! ? #WomenCorporateDirectors #pHPartners #pHBlueprint #pHHealth #StrategicAdvising #Biotech #LifeSciences #Healthcare

We're proud to announce that CollectiveCare Dental (CCD) has partnered with Source Capital, securing an equity investment to fuel its next phase of growth. As CCD’s exclusive financial advisor, we guided them in identifying a partner aligned with their vision for excellence and expansion. This partnership enables CCD to: ??Restructure and recapitalize for growth ? Gain Access to a new debt facility ??Expand?M&A &?operations across Pennsylvania, Delaware, and New Jersey ? Huge?congratulations?to the teams at CollectiveCare Dental and Source Capital! We’re excited to see the amazing growth and impact this collaboration will have. #DentalCare?#SBIC?#Dental #DSO?#Partnership #Growth #Success

This week, we explore the importance of freedom-to-operate in the latest installment of the IP Strategy series by John Storella, an expert partner with pH Blueprint. Having the freedom to operate is a critical part of a robust patent portfolio. Without it, entering the market could lead to legal obstacles that can halt progress. From early product development stages to final launch, continuous freedom-to-operate analyses are key to mitigating risks and ensuring market entry. Learn more about how strategic IP planning can safeguard your innovation and market position at the link below. ?#IPstrategy ?#IP #IPplanning ?#patentprotection #freedomtooperate ?#innovation ?#diagnostics ?#biotech ?#lifesciences #healthcare ?#strategicadvising ?#leadership

Meet Ramon Benet,?board?advisor?at?pH Blueprint! Ramon brings over 35 years of leadership experience in the in vitro diagnostics Medical Device industry. As the former President and CEO of Instrumentation Laboratory, a?Werfen company, Ramon drove the company to an average annual growth rate of more than double the industry standard. His extensive background includes marketing and sales roles at? Centocor, Ortho Clinical Diagnostics (Johnson & Johnson), and Ciba-Geigy (now?Novartis). Ramon has also served as a Trustee at the Committee for Economic Development and on the Board of Directors for AdvaMed?and MassMEDIC . Ramon is a Principal at Device Solutions, LLC, a?Venture Partner at Asabys Partners, and a Business Advisor at MiMARK. He is also a?member of Hub Investment Management Group and Mass Medical Angels. Previously, he was a Venture Partner at Nina Capital, a member of Sky Ventures Group, and a Board Advisor at?NitriCap Medical Inc. Ramon holds a law degree from the Universitat de Barcelona and an MBA from IESE Business School. ? We are thrilled to have Ramon on our board! He brings his deep industry knowledge and strategic insights to drive growth and innovation at pH Health. #innovation #diagnostics #medicaldevice #biotech #lifesciences #strategicadvising #leadership?

At pH Blueprint, our mission is to leverage our decades of collective experiences and vast networks to benefit our clients.?We have?been there, leading companies through every stage, and will provide expert insight to transform ideas and technology into sustainable products Stay tuned! Over the next two weeks, we'll share our?executive team's backgrounds and unique perspectives on the industries we serve. #innovation #diagnostics #medicaldevice #biotech #lifesciences #strategicadvising

We are thrilled to announce that Gareth Petsch, a seasoned professional with 24+ years in the healthcare services industry and a proven track record in debt advisory, has joined pH Partners to lead our Debt Advisory and Healthcare Services vertical. Previously, Gareth was a Partner at a Healthcare Services Private Equity firm, where he successfully executed multiple M&A transactions and fundraising initiatives. He also founded the Citi Commercial Bank Healthcare Services team in 2012, catering to the specialized needs of medical, dental, and veterinary providers across the private sector to large-scale group practices. With Gareth's extensive background, we are confident in his ability to lead pH Partners through its next phase of growth. For more insights, please visit our website at https://lnkd.in/gZMBwb63